[1]
2015. Bevacizumab in HER2neu Negative Locally Recurrent and Metastatic Breast Cancer: The BHerN Review . Acta Medica Philippina. 49, 2 (Jun. 2015). DOI:https://doi.org/10.47895/amp.v49i2.991.